Reports

Find out about us through our annual reports, financial statements and reviews, or read other reports about our work.

Skip to results

Refine results

Showing all

Showing 1 to 20 results of 455

Sorted by most recent

Report 6 April 2022 Updated 6 April 2022

Understanding the antibiotic manufacturing ecosystem

This report, commissioned by Wellcome and produced by Boston Consulting Group, brings together data to map global antibiotic supply chains with economic analysis to explore the viability of measures to limit antibiotic discharge in manufacturing effluent.
Report 16 February 2022 Updated 16 February 2022

The Wellcome CPD Challenge: Pilot Delivery Report

The Wellcome CPD Challenge, which ran from 2018-2021 in 40 schools across South Yorkshire, explored the changes needed in the education system to allow all teachers to take part in high-quality, predominantly subject-specific CPD.
Report 16 February 2022 Updated 16 February 2022

The Wellcome CPD Challenge: Evaluation Final Report

The Wellcome CPD Challenge, which ran from 2018-2021 in 40 schools across South Yorkshire, explored the changes needed in the education system to allow all teachers to take part in high-quality, predominantly subject-specific CPD.
Report 11 January 2022 

Wellcome Annual Report 2021

Wellcome's Annual Report 2021 describes our activities during the past year, and reviews our finances and investments.

Report 29 November 2021 

Wellcome Global Monitor 2020: Covid-19

How the Covid-19 crisis has affected people around the world and influenced their trust in science, healthcare systems and governments.

Report 25 October 2021 

Improving global pandemic preparedness by 2025

This paper outlines three areas – global coordination and leadership; financing and how to address key gaps in pandemic infrastructure – that will have the biggest impact on future global preparedness. 

Report 25 October 2021 

Addressing Covid-19 vaccine inequity by mid-2022

Across the world, there are unacceptable disparities in access to Covid-19 vaccines, leaving many vulnerable people unprotected. This paper considers this challenge and sets out the action needed by G20 countries and vaccine manufacturers to rapidly increase global vaccination rates, with the aim of reaching 70% of the population in every country by June 2022.